Efficacy and feasibility of the Integrated Psychological Therapy for outpatients with schizophrenia in Greece: Final results of a RCT

Psychiatry Research

Volumn 242, Issue , 2016, Pages 137-143

  Rakitzi, Stavroula ^a   Georgila, Polyxeni ^b   Efthimiou, Konstantinos ^c   Mueller, Daniel R ^d  

^a Private Practice   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c Institute of Behavioural Research and Therapy   (Greece)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Negative symptoms; Neurocognition; Psychosis; Rehabilitation; Social cognition

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE REMEDIATION THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GREECE; HUMAN; INTEGRATED PSYCHOLOGICAL THERAPY; MALE; NEUROCOGNITION; OUTPATIENT; PERCEPTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL COGNITION; SOCIAL PSYCHOLOGY; THERAPY EFFECT; TREATMENT DURATION; WORKING MEMORY; COGNITIVE THERAPY; GROUP THERAPY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; SOCIAL BEHAVIOR; TREATMENT OUTCOME;

ADULT; COGNITION; COGNITIVE THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR; SOCIAL PERCEPTION; TREATMENT OUTCOME;

EID: 84973162624     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.05.039     Document Type: Article

References (57)

1. American Psychiatric Association, 2004. DSM-IV-TR. Diagnostic criteria. DSM-IV-TR. Litsas, Athens.
2. Aster, M., Neubauer, M., Horn, R., 2006. Wechsler-Intelligenztest für Erwachsene WIE. Harcourt Test Services, Frankfurt.
3. Bell M.D., Corbera S., Johannesen J.K., Fiszdon J.M., Wexler B.E. Social cognitive impairments and negative symptoms in Schizophrenia: are there subtypes with distinct functional correlates?. Schizophr. Bull. 2013, 39(1):186-196.
4. Bortz J., Döring N. Forschungsmethoden und Evaluation für Human- und Sozialwissenschaftler 2002, Springer, Berlin.
5. Brekke J.S., Nakagami E. The relevance of neurocognition and social cognition for outcome and recovery in schizophrenia. Neurocognition and Social Cognition in Schizophrenia Patients 2010, 23-36. Karger, Basel. V. Roder, A. Medalia (Eds.).
6. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 2007, 33(4):1013-1022.
7. Cohen J. Statistical Power Analyses for the Behavioural Sciences 1988, Erlbaum, Hillsdale, NJ.
8. Efthimiou K., Rakitzi S., Roder V. A cognitive behavioural group therapy program for the improvement of the cognitive and social abilities of patients with schizophrenia. Psychiatriki 2009, 20:245-254.
9. Fett A.K.J., Maat A., GROUP, Investigators Social cognitive impairments and psychotic symptoms: what is the nature of their association?. Schizophr. Bull. 2013, 39(1):77-85.
10. Fioravanti M., Bianchi V., Cinti M.E. Cognitive deficits in schizophrenia: an updated meta-analysis of the scientific evidence. BMC Psychiatry 2012, 12(64):1-20.
11. Fuentes I., Garcia S., Ruiz J.C., Soler J., Roder V. Social perception scale in Schizophrenia. A pilot study. Int. J. Psychol. Psychol. Ther. 2007, 7(1):1-12.
12. Garcia S., Fuentes I., Ruiz J.C., Gallach E., Roder V. Application of the IPT in a Spanish sample: evaluation of the "social Perception subprogram". Int. J. Psychol. Psychol. Ther. 2003, 3(2):299-310.
13. Ginieri-Coccosis, M., Triantafillou, E., Antonopoulou, V., Tomaras, V., Christodoulou, G., 2003. The Greek Manual of WHOQOL-100. Vita, Athens.
14. Ginieri-Coccosis M., Triantafillou E., Tomaras V., Soldatos C., Mavreas V., Christodoulou G. Psychometric properties of WHOQOL-BREF in clinical and healthy Greek populations: Incorporating new culture-relevant items. Psychiatriki 2012, 23(2):130-142.
15. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and winsconsin card sorting test performance in Schizophrenia. Arch. Gen. Psychiatry 1997, 54(2):159-165.
16. Green M.F., Bearden C.E., Cannon T.D., Fiske A.P., Hellemann G.S., Horan W.P., Kee K., Kern R.S., Lee J., Sergi M.J., Subotnik K.L., Sugar C.A., Ventura J., Yee C.M., Nuechterlein K.M. Social cognition in schizophrenia, part 1: performance across phase of illness. Schizophr. Bull. 2012, 38(4):854-864.
17. Green M.F., Olivier B., Crawley J.N., Penn D.L., Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr. Bull. 2005, 31(4):882-887.
18. Hovington C.L., Bodnar M., Joober R., Malla A.K., Lepage M. Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms. Schizophr. Res. 2013, 147(2-3):223-229.
19. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
20. Kirkpatrik B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
21. Kirkpatrik B. Progress in the study of negative symptoms. Schizophr. Bull. 2014, 40(Suppl. 2):S101-S106.
22. Klingberg S., Wölwer W., Engel C., Wittorf A., Herrlich J., Meisner C., Buchkremer G., Wiedermann G. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr. Bull. 2011, 37(Suppl. 2):S98-S110.
23. Kosmidou, M., 2002. The greek verbal memory Test. In: Stalikas, A., Triliva, S., Roussi, S. (Eds.), The Psychometric Tests in Greece. Greek letters, Athens, p. 171.
24. Kurtz M.M., Moberg P.J., Gur R.C. Approaches to remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol. Rev. 2001, 11(4):197-210.
25. Kurtz M.M., Richardson C.L. Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophr. Bull. 2012, 38(5):1092-1104.
26. Leucht S., Cipriani A., Spineli L., Mavridis D., Orey D., Richter F., Samara M., Barbui C., Engel R.R., Geddes J.R., Kissling W., Stapf M.P., Lässig B., Salanti G., Davis J.M. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013, 382(9896):951-962.
27. Lincoln T., Mehl S., Kesting M.L., Rief W. Negative symptoms and social cognition: identifying targets for psychological interventions. Schizophr. Bull. 2011, 37(Suppl. 2):S23-S32.
28. Lykouras L., Botsis A., Oulis P. The PANSS Scale 2005, Scientific Publications, Athens.
29. Lysaker P.H., Dimaggio G., Buck K.D., Callaway S.S., Salvatore G., Carcione A., Nicolo G., Stanghellini G. Poor insight in schizophrenia: links between different forms of metacognition with awareness of symptoms, treatment need, and consequences of illness. Compr. Psychiatry 2011, 52(3):253-260.
30. Mass R. Das Vigilanzparadigma in der Schizophrenieforschung. Fort. Neurol. Psychiatry 2002, 70(1):34-39.
31. McGurk S.R., Twamley W.T., Sitzer D.I., McHugo G.J., Mueser K.T. A Meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
32. Mueller D.R., Schmidt S.J., Roder V. Integrated Psychological Therapy (IPT): effectiveness in schizophrenia inpatient settings related to patients age. Am. J. Geriatr. Psychiatry 2013, 21(3):231-241.
33. Mueller D.R., Schmidt S.J., Roder V. One-year randomized controlled trial and follow-up of Integrated Neurocognitive Therapy for schizophrenia outpatients. Schizophr. Bull. 2015, 41(3):604-616.
34. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72(1):29-39.
35. Nuechterlein, K.H., Green, M.F., 2006. Matrics Consensus cognitve battery. MATRICS. MATRICS Assessment Inc, Los Angeles.
36. Rakitzi, S., 2007a. The Letter Number Span in Greek. Translation. Unpublished.
37. Rakitzi, S., 2007b. The Social Perception Scale in Greek. Unpublished.
38. Robertson D.A., Hargreaves A., Kelleher E.B., Morris D., Gill M., Corvin A., Donohoe G. Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition. Schizophr. Res. 2013, 146(1-3):363-365.
39. Robertson B.R., Prestia D., Twamley E.W., Patterson T.L., Bowie C.R., Harvey P.D. Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia. Schizophr. Res. 2014, 160(1-3):136-141.
40. Roder V., Brenner H.D., Kienzle N., Efthimiou Κ Τhe GREeK MANUAL OF Integrated Psychological Therapy. (Ι. Ρ. Τ.) 2007, Scientific Publications, Athens.
41. Roder V., Brenner H.D., Kienzle N. Integriertes Psychologisches Therapieprogramm bei schizophren Erkrankten. IPT 2008, Beltz, Weinheim.
42. Roder V., Mueller D.R. Psychotherapie der Schizophrenie. Spec. Psychiatr. 2008, 1:26-28.
43. Roder V., Mueller D., Mueser K., Brenner H.D. Integrated Psychological Therapy (IPT) for Schizophrenia: Is it effective?. Schizophr. Bull. 2006, 32(Suppl. 1):S81-S93.
44. Roder, V., Mueller, D.R., Brenner, H.D., Spaulding, W., 2010. Integrated Psychological Therapy (IPT) for the Treatment of Neurocognition, Social Cognition and Social Competency in Schizophrenia Patients. Hogrefe & Huber, Seattle, WA.
45. Roder V., Mueller D.R., Schmidt S.J. Effectiveness of Integrated Psychological Therapy (IPT) for schizophrenia patients. Schizophr. Bull. 2011, 37(Suppl. 2):S71-S79.
46. Ruiz, J.C., Garcia, S., Fuentes, I., Garcia-Merita, M., 2005. SPS: A scale for the assessment of social perception in schizophrenia. VII International Symposium on Schizophrenia. Bern, Switzerland.
47. Sachs G. Neurokognition und Schizophrenie. Spec. Psychiatr. 2008, 1:16-18.
48. Schmidt S., Mueller D.R., Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: Empirical review and new results by structural equation modeling. Schizophr. Bull. 2011, 37(Suppl. 2):S41-S54.
49. Startup M., Jackson M.C., Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br. J. Clin. Psychol. 2002, 41(4):417-422.
50. Strassnig M.T., Raykov T., O'Gorman C., Bowie C.R., Sabbag S., Durand D., Harvey P.D. Determinants of different aspects of everyday outcome in schizophrenia: the roles of negative symptoms, cognition and functional capacity. Schizophr. Res. 2015, 165(1):76-82.
51. Suwa H., Matsushima E., Otha K., Mori K. Attention disorders in schizophrenia. Psychol. Clin. Neurosci. 2004, 58:249-256.
52. Tandon R. Antipsychotics in the treatment of schizophrenia: an overview. J. Clin. Psychiatry 2011, 72(Suppl. 1):S4-S8.
53. Velligan D., Maples N., Roberts D.L., Medelin E.M. Integrated psychosocial treatment for negative symptoms. Am. J. Psychiatr. Rehab. 2014, 17(1):1-19.
54. Ventura J., Subotnik K.L., Ered A., Gretchen-Doorly D., Hellenmann G.S., Vaskinn A., Nuechterlein K.H. The relationship of attitudional beliefs to negative symptoms, neurocognition and daily functioning in recent-onset schizophrenia. Schizophr. Bull. 2014, 40(6):1308-1318.
55. Ventura J., Tom S.R., Jetton C., Kern R.S. Memory functioning and negative symptoms as differential predictors of social problem solving skills in schizophrenia. Schizophr. Res. 2013, 143(2-3):307-311.
56. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.
57. Wykes T., Spaulding W.D. Thinking about cognitive remediation therapy - what works and could we do better?. Schizophr. Bull. 2011, 37(Suppl. 2):S80-S90.